179 related articles for article (PubMed ID: 18840581)
21. Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig.
Jormalainen M; Vento AE; Wartiovaara-Kautto U; Suojaranta-Ylinen R; Lauronen J; Paavonen T; Petäjä J
Acta Anaesthesiol Scand; 2007 Feb; 51(2):178-88. PubMed ID: 17096669
[TBL] [Abstract][Full Text] [Related]
22. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy.
Rondelet B; Kerbaul F; Van Beneden R; Motte S; Fesler P; Hubloue I; Remmelink M; Brimioulle S; Salmon I; Ketelslegers JM; Naeije R
Circulation; 2004 Oct; 110(15):2220-5. PubMed ID: 15466636
[TBL] [Abstract][Full Text] [Related]
23. Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits.
Bremer YA; Salloum F; Ockaili R; Chou E; Moskowitz WB; Kukreja RC
Pediatr Res; 2005 Jan; 57(1):22-7. PubMed ID: 15531735
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
25. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
26. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension.
Dias-Junior CA; Souza-Costa DC; Zerbini T; da Rocha JB; Gerlach RF; Tanus-Santos JE
Anesth Analg; 2005 Jul; 101(1):115-20, table of contents. PubMed ID: 15976216
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
28. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
29. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
30. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J
J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688
[TBL] [Abstract][Full Text] [Related]
31. [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].
Wodniecki J; Jacheć W; Poloński L; Tomasik AR; Wojciechowska C; Foremny A
Przegl Lek; 2005; 62(2):135-8. PubMed ID: 16095162
[TBL] [Abstract][Full Text] [Related]
32. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.
Mikhail GW; Prasad SK; Li W; Rogers P; Chester AH; Bayne S; Stephens D; Khan M; Gibbs JS; Evans TW; Mitchell A; Yacoub MH; Gatzoulis MA
Eur Heart J; 2004 Mar; 25(5):431-6. PubMed ID: 15033256
[TBL] [Abstract][Full Text] [Related]
33. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism.
Dias-Junior CA; Montenegro MF; Florencio BC; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):374-9. PubMed ID: 18834358
[TBL] [Abstract][Full Text] [Related]
34. Nebulized phosphodiesterase III inhibitor during warm ischemia attenuates pulmonary ischemia-reperfusion injury.
Zhang J; Chen F; Zhao X; Aoyama A; Okamoto T; Fujinaga T; Shoji T; Sakai H; Cui Y; Bando T; Date H
J Heart Lung Transplant; 2009 Jan; 28(1):79-84. PubMed ID: 19134535
[TBL] [Abstract][Full Text] [Related]
35. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats.
Dai ZK; Tan MS; Chai CY; Chou SH; Lin PC; Yeh JL; Jeng AY; Chang CI; Chen IJ; Wu JR
Exp Biol Med (Maywood); 2006 Jun; 231(6):942-7. PubMed ID: 16741028
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
37. Sildenafil prevents cardiovascular changes after bone marrow fat embolization in sheep.
Krebs J; Ferguson SJ; Nuss K; Leskosek B; Hoerstrup SP; Goss BG; Aebli N
Anesthesiology; 2007 Jul; 107(1):75-81. PubMed ID: 17585218
[TBL] [Abstract][Full Text] [Related]
38. Sildenafil citrate alleviates pulmonary hypertension after hypoxia and reoxygenation with cardiopulmonary bypass.
Lyons JM; Duffy JY; Wagner CJ; Pearl JM
J Am Coll Surg; 2004 Oct; 199(4):607-14. PubMed ID: 15454147
[TBL] [Abstract][Full Text] [Related]
39. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
40. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
